AMEX · Financial Statements
Can-Fite BioPharma Ltd. (CANF) Financial Statements
$3.30
AMEX: CANF
Market Cap $1.78M
Overview Financials Dividend Can-Fite BioPharma Ltd. most recently reported annual revenue of $0, net profit of $-10.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $1.0M $1.0M $1.0M $1.0M $0 Operating Profit $-13.0M $-10.0M $-8.0M $-8.0M $-10.0M Net Profit $-13.0M $-10.0M $-8.0M $-8.0M $-10.0M EPS $-8.25 $-3.75 $-1.80 $-1.08 $-12.03 Op Margin -1505.5% -1246.4% -1103.0% -1206.2% -2456.8%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $20.0M $9.0M $10.0M $9.0M $10.0M Total Liabilities $6.0M $5.0M $4.0M $4.0M $4.0M Cash $4.0M $3.0M $4.0M $5.0M $6.0M Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-10.0M $-11.0M $-8.0M $-8.0M $-9.0M Investing Cash Flow $-15.0M $9.0M $0 $1.0M $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $-4.0M $-1.0M $1.0M $1.0M $1.0M Free Cash Flow $-10.0M $-11.0M $-8.0M $-8.0M $-9.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.01 EV / EBITDA -882.18 FCF Yield -0.10% Quick Ratio 3.46 Interest Coverage 0.00 Return 1Y -83.82% Return 3Y -94.50% Return 5Y -99.23%
Screens featuring this stock